Trump says the U.S. is the highest taxed country in the world. It’s not.

On Wednesday, President Trump twice said the United States is “the highest taxed nation in the world.”

No, it’s not.

In fact, Trump has made the very same blanket claim at least 18 times before, according to the Committee for a Responsible Federal Budget.

Here are just a few ways the United States trails other countries in terms of taxation.


Top Heal Care Stocks To Invest In 2018

We know that the U.S. population is aging. 10,000 Baby Boomers turn 65 every day. Maybe that’s more than you thought. Maybe that’s less. But in absolute terms, it’s a lot of people requiring specialized housing (with long-term care option on site, for example) and a statistic that grows as the years go by. This yields very attractive economics in the demand for senior housing,....More>>>

Litecoin Prices Plunge As Crypto Markets Suffer Sell-Off

Litecoin plunged to roughly half its all-time high earlier today. Shutterstock

Litecoin prices fell today, dropping to roughly half of the all-time high they reached earlier this month.

The digital currency declined to as little as $46.04 earlier in the day, roughly 50% lower than the high of $92.07 it hit on September 2,....More>>>

Top Clean Energy Stocks To Watch Right Now

Shaw Communications (NYSE:SJR) has seen a strong reaction in its stock price in response to its 2nd quarter earnings report that showed significant subscriber performance in its cable and wireless segments. This was especially surprising as the company had lowered expectations ahead of the quarter. However, we think that the company is currently overvalued as it trades at a premium in forward EV/EBITDA....More>>>

Top Biotech Stocks To Own Right Now

The management of regulatory affairs essentially contributes to the overall success of new drug development – both at early pre-marketing stages and at all times post-marketing. This means that a biotech or pharma company’s regulatory affairs personnel will be heavily involved in all stages of new drug development both prior to and after an FDA approval.